Wednesday, September 9, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $316.22 -1.17%
MSFT $493.95 -1.15%
GOOGL $338.36 -0.03%
AMZN $256.97 -0.60%
TSLA $368.16 +3.98%
META $613.48 -0.53%
NVDA $225.73 -2.01%
JPM $353.51 -1.43%
BTC $34.68 -1.78%
ETH $23.68 +1.07%
AAPL
$316.22
▼ 1.17%
MSFT
$493.95
▼ 1.15%
GOOGL
$338.36
▼ 0.03%
AMZN
$256.97
▼ 0.60%
TSLA
$368.16
▲ 3.98%
META
$613.48
▼ 0.53%
NVDA
$225.73
▼ 2.01%
JPM
$353.51
▼ 1.43%
Bloomberg Markets
Novartis saw a treatment for a rare muscle-wasting disease fail a late-stage study, the third clinical-trial setback in a week. The medicine was the centerpiece of Novartis’s $12 billion takeover of Avidity Biosciences and raises questions about the drugmaker’s growth prospects. Fabienne Kinzelmann reports on Bloomberg Television. (Source: Bloomberg)
business  15h ago
Bloomberg Markets
David Cowan, Africa Economist at Citi Research, says South Africa has yet to turn the corner on growth, with the economy showing resilience rather than a strong acceleration. He also says Zimbabwe’s recovery is benefiting from improved fiscal discipline, higher gold and lithium prices and stronger agricultural exports. Cowan discusses the challenges of de-dollarization, signs of renewed foreign investor interest and the importance of Zimbabwe getting its lithium policy right with Abeer Abu Omar
business  15h ago
Bloomberg Markets
Franklin Templeton Inc. is buying a majority stake in Stoneshield Capital, a European investment firm specializing in real estate and infrastructure, in the latest move by the US money manager to expand further into alternative assets.
business  16h ago

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free